Full Text View
Tabular View
Study Results
Related Studies
Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)
This study has been terminated.
( Poor accrual, changes in management of newly diagnosed myeloma patients, new drugs/more effective regimens. )
Study NCT00215943   Information provided by H. Lee Moffitt Cancer Center and Research Institute

First Received on September 15, 2005.   Last Updated on April 1, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial